Biodesix Inc (BDSX)

$17.88 -1.27 (-6.63%)
Market Cap 176.27M
Revenue (ttm) 88.50M
Net Income (ttm) -35.27M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -39.85%
Debt to Equity Ratio -19.21
Volume 119,400
Avg Vol 1,773,692
Day's Range N/A - N/A
Shares Out 9.86M
Stochastic %K 59%
Beta 0.59
Analysts Strong Sell
Price Target $30.00

Company Profile

Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy,...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 303 417 0500
Fax: 866 432 3338
Address:
919 West Dillon Road, Louisville, United States
Word0025
Word0025 Mar. 12 at 2:06 PM
$BDSX reached 52wh
0 · Reply
stockToph
stockToph Mar. 6 at 6:12 PM
$BDSX 💃💃💃💃🤑💰💵
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 27 at 7:24 PM
$BDSX Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.49 up 56.64% YoY • Reported revenue of $28.75M up 40.76% YoY • Biodesix anticipates FY2026 total revenue guidance of $106M, a 23% growth over 2025, and expects to maintain approximately 80% gross margin. Biodesix also forecasts continued improvement toward sustained Adjusted EBITDA positivity.
0 · Reply
Baseball89
Baseball89 Feb. 27 at 5:51 PM
$BDSX $NCNA & $IMRN keep watch.Sleeping giant!!!
0 · Reply
WiseSolution
WiseSolution Feb. 27 at 3:53 PM
$BDSX like the 3 year chart. 20s soon with low float and upbeat earnings
0 · Reply
topstockalerts
topstockalerts Feb. 27 at 2:44 PM
$BDSX Showing strong relative strength versus the market. It’s holding gains while others chop. That’s a bullish sign.
0 · Reply
Rebel876
Rebel876 Feb. 27 at 2:30 PM
$BDSX is this a safe buy Now
2 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 26 at 9:09 PM
$BDSX Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.49 up 56.64% YoY • Reported revenue of $28.75M up 40.76% YoY • Biodesix anticipates generating $106M in total revenue in 2026, representing 23% growth, and expects continued improvement toward sustained Adjusted EBITDA positivity, with gross margin maintained at approximately 80%.
0 · Reply
tsouw
tsouw Feb. 26 at 1:30 PM
$BDSX I'm so mad I bought at 6$ and sold at 8$, didn't see that jump coming. Well good for the ones who hold
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 23 at 10:06 PM
$BDSX RSI: 68.02, MACD: 1.0522 Vol: 1.15, MA20: 11.02, MA50: 9.00 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Latest News on BDSX
Biodesix, Inc. (BDSX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Mar 11, 2026, 1:52 PM EDT - 4 days ago

Biodesix, Inc. (BDSX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Biodesix, Inc. (BDSX) Q4 2025 Earnings Call Transcript

Feb 26, 2026, 9:17 PM EST - 17 days ago

Biodesix, Inc. (BDSX) Q4 2025 Earnings Call Transcript

Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights

Feb 26, 2026, 4:01 PM EST - 17 days ago

Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights

Biodesix to Participate in Upcoming Investor Conferences

Feb 24, 2026, 6:00 AM EST - 20 days ago

Biodesix to Participate in Upcoming Investor Conferences

Biodesix to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Feb 12, 2026, 6:00 AM EST - 4 weeks ago

Biodesix to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Biodesix Announces Preliminary Fourth Quarter and Full-Year 2025 Results (Unaudited)

Jan 12, 2026, 6:00 AM EST - 2 months ago

Biodesix Announces Preliminary Fourth Quarter and Full-Year 2025 Results (Unaudited)

Biodesix to Present New Data at Two Major Upcoming Scientific Meetings

Dec 3, 2025, 8:22 AM EST - 3 months ago

Biodesix to Present New Data at Two Major Upcoming Scientific Meetings

Biodesix, Inc. (BDSX) Q3 2025 Earnings Call Transcript

Nov 3, 2025, 10:46 PM EST - 4 months ago

Biodesix, Inc. (BDSX) Q3 2025 Earnings Call Transcript

Biodesix Announces Third Quarter 2025 Results and Highlights

Nov 3, 2025, 4:01 PM EST - 4 months ago

Biodesix Announces Third Quarter 2025 Results and Highlights

Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting

Oct 30, 2025, 6:17 AM EDT - 4 months ago

Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting

Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays

Oct 22, 2025, 6:17 AM EDT - 5 months ago

Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays

Biodesix to Report Third Quarter 2025 Financial Results on November 3, 2025

Oct 20, 2025, 6:00 AM EDT - 5 months ago

Biodesix to Report Third Quarter 2025 Financial Results on November 3, 2025

Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting

Oct 15, 2025, 6:09 AM EDT - 5 months ago

Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting

Biodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American Lung Association in Colorado, and GO2 for Lung Cancer Centers of Excellence Summit

Oct 6, 2025, 10:13 AM EDT - 5 months ago

Biodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American Lung Association in Colorado, and GO2 for Lung Cancer Centers of Excellence Summit

Biodesix Announces One-for-Twenty Reverse Stock Split

Sep 11, 2025, 8:00 AM EDT - 6 months ago

Biodesix Announces One-for-Twenty Reverse Stock Split

Biodesix to Participate in Lake Street Capital Markets' 9th Annual Best Ideas Growth (BIG9) Conference

Sep 5, 2025, 6:00 AM EDT - 6 months ago

Biodesix to Participate in Lake Street Capital Markets' 9th Annual Best Ideas Growth (BIG9) Conference

Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS Diagnostics

Aug 19, 2025, 9:47 AM EDT - 7 months ago

Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS Diagnostics

Biodesix, Inc. (BDSX) Q2 2025 Earnings Call Transcript

Aug 9, 2025, 11:07 AM EDT - 7 months ago

Biodesix, Inc. (BDSX) Q2 2025 Earnings Call Transcript

Biodesix Announces Second Quarter 2025 Results and Highlights

Aug 7, 2025, 4:06 PM EDT - 7 months ago

Biodesix Announces Second Quarter 2025 Results and Highlights

Biodesix to Present at the Canaccord Genuity 45th Annual Growth Conference

Aug 5, 2025, 6:00 AM EDT - 7 months ago

Biodesix to Present at the Canaccord Genuity 45th Annual Growth Conference

Biodesix to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 24, 2025, 6:00 AM EDT - 8 months ago

Biodesix to Report Second Quarter 2025 Financial Results on August 7, 2025

Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation's First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs

Jun 10, 2025, 6:17 AM EDT - 9 months ago

Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation's First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs

Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting

May 22, 2025, 5:03 PM EDT - 10 months ago

Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting

Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS

May 15, 2025, 6:00 AM EDT - 10 months ago

Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS

Denver Post Names Biodesix a Winner of Top Workplaces 2025 Award

May 14, 2025, 4:01 PM EDT - 10 months ago

Denver Post Names Biodesix a Winner of Top Workplaces 2025 Award

Biodesix, Inc. (BDSX) Q1 2025 Earnings Call Transcript

May 13, 2025, 8:22 PM EDT - 10 months ago

Biodesix, Inc. (BDSX) Q1 2025 Earnings Call Transcript

Biodesix Announces First Quarter 2025 Results and Highlights

May 13, 2025, 4:01 PM EDT - 10 months ago

Biodesix Announces First Quarter 2025 Results and Highlights

Biodesix to Report First Quarter 2025 Financial Results on May 13, 2025

Apr 29, 2025, 6:00 AM EDT - 11 months ago

Biodesix to Report First Quarter 2025 Financial Results on May 13, 2025

Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types

Apr 23, 2025, 6:00 AM EDT - 11 months ago

Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types

Biodesix, Inc. (BDSX) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 8:06 PM EST - 1 year ago

Biodesix, Inc. (BDSX) Q4 2024 Earnings Call Transcript

Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results

Mar 3, 2025, 4:01 PM EST - 1 year ago

Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results

Biodesix to Present at TD Cowen 45th Annual Health Care Conference

Feb 26, 2025, 6:00 AM EST - 1 year ago

Biodesix to Present at TD Cowen 45th Annual Health Care Conference

Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Feb 18, 2025, 6:00 AM EST - 1 year ago

Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited)

Jan 10, 2025, 6:00 AM EST - 1 year ago

Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited)

Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study

Jan 7, 2025, 6:00 AM EST - 1 year ago

Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study

Biodesix, Inc. (BDSX) Q3 2024 Earnings Call Transcript

Nov 1, 2024, 3:29 PM EDT - 1 year ago

Biodesix, Inc. (BDSX) Q3 2024 Earnings Call Transcript

Biodesix Announces Third Quarter 2024 Results and Highlights

Nov 1, 2024, 6:00 AM EDT - 1 year ago

Biodesix Announces Third Quarter 2024 Results and Highlights

Biodesix to Participate in Three Investor Conferences in November

Oct 29, 2024, 6:00 AM EDT - 1 year ago

Biodesix to Participate in Three Investor Conferences in November

Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024

Oct 18, 2024, 6:00 AM EDT - 1 year ago

Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024

Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study

Oct 7, 2024, 6:00 AM EDT - 1 year ago

Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study

Biodesix to Present at Two Investor Conferences in September

Sep 5, 2024, 6:00 AM EDT - 1 year ago

Biodesix to Present at Two Investor Conferences in September

Biodesix, Inc. (BDSX) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 8:52 PM EDT - 1 year ago

Biodesix, Inc. (BDSX) Q2 2024 Earnings Call Transcript

Biodesix Announces Second Quarter 2024 Results and Highlights

Aug 7, 2024, 4:01 PM EDT - 1 year ago

Biodesix Announces Second Quarter 2024 Results and Highlights

Biodesix to Present at Canaccord Genuity's 44th Annual Growth Conference

Aug 6, 2024, 6:00 AM EDT - 1 year ago

Biodesix to Present at Canaccord Genuity's 44th Annual Growth Conference

Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024

Jul 24, 2024, 6:00 AM EDT - 1 year ago

Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024

Biodesix Named to Inc. Magazine's 2024 “Best Workplaces”

Jun 18, 2024, 8:13 AM EDT - 1 year ago

Biodesix Named to Inc. Magazine's 2024 “Best Workplaces”

Biodesix to Participate in Two Investor Conferences in June

May 28, 2024, 6:00 AM EDT - 1 year ago

Biodesix to Participate in Two Investor Conferences in June

Biodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual Meeting

May 21, 2024, 6:00 AM EDT - 1 year ago

Biodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual Meeting

Biodesix, Inc. (BDSX) Q1 2024 Earnings Call Transcript

May 10, 2024, 1:06 AM EDT - 2 years ago

Biodesix, Inc. (BDSX) Q1 2024 Earnings Call Transcript

Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management

May 8, 2024, 4:01 PM EDT - 2 years ago

Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management

Word0025
Word0025 Mar. 12 at 2:06 PM
$BDSX reached 52wh
0 · Reply
stockToph
stockToph Mar. 6 at 6:12 PM
$BDSX 💃💃💃💃🤑💰💵
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 27 at 7:24 PM
$BDSX Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.49 up 56.64% YoY • Reported revenue of $28.75M up 40.76% YoY • Biodesix anticipates FY2026 total revenue guidance of $106M, a 23% growth over 2025, and expects to maintain approximately 80% gross margin. Biodesix also forecasts continued improvement toward sustained Adjusted EBITDA positivity.
0 · Reply
Baseball89
Baseball89 Feb. 27 at 5:51 PM
$BDSX $NCNA & $IMRN keep watch.Sleeping giant!!!
0 · Reply
WiseSolution
WiseSolution Feb. 27 at 3:53 PM
$BDSX like the 3 year chart. 20s soon with low float and upbeat earnings
0 · Reply
topstockalerts
topstockalerts Feb. 27 at 2:44 PM
$BDSX Showing strong relative strength versus the market. It’s holding gains while others chop. That’s a bullish sign.
0 · Reply
Rebel876
Rebel876 Feb. 27 at 2:30 PM
$BDSX is this a safe buy Now
2 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 26 at 9:09 PM
$BDSX Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.49 up 56.64% YoY • Reported revenue of $28.75M up 40.76% YoY • Biodesix anticipates generating $106M in total revenue in 2026, representing 23% growth, and expects continued improvement toward sustained Adjusted EBITDA positivity, with gross margin maintained at approximately 80%.
0 · Reply
tsouw
tsouw Feb. 26 at 1:30 PM
$BDSX I'm so mad I bought at 6$ and sold at 8$, didn't see that jump coming. Well good for the ones who hold
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 23 at 10:06 PM
$BDSX RSI: 68.02, MACD: 1.0522 Vol: 1.15, MA20: 11.02, MA50: 9.00 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
WiseSolution
WiseSolution Feb. 18 at 2:54 PM
$BDSX seems a breakout with 16s on deck now
1 · Reply
stockToph
stockToph Feb. 13 at 3:47 PM
$BDSX woo hoo!
0 · Reply
WiseSolution
WiseSolution Feb. 9 at 9:20 AM
$BDSX the new S8 will issue about 300k shares for stock incentive program. Actually good news. In the past they kept adding debt and I was expecting maybe an offering to raise funds. Maybe they have turned a corner? If they were going raise capital this probably would have been combined with this offering
0 · Reply
Red2Profit
Red2Profit Jan. 31 at 11:26 PM
$BDSX Looking for a retest of the daily 50ema and take liquiidty at 7.80, break 11.87 then target 16.23 and 25.98. We'll get a sall reaction from technicals but need a catalyst for the higher levels.
1 · Reply
WiseSolution
WiseSolution Jan. 29 at 3:20 PM
$BDSX well so much for insiders buying and funds adding. Lets see if we test 8.00 level
1 · Reply
Zezo88
Zezo88 Jan. 28 at 3:38 PM
$BDSX added 10.5- 11 eod
0 · Reply
SocioCobb
SocioCobb Jan. 27 at 3:42 PM
$BDSX bullish!
0 · Reply
WiseSolution
WiseSolution Jan. 27 at 3:34 PM
$BDSX more insider buying and fund adding. Should test the 12.50 area again soon
0 · Reply
Philox
Philox Jan. 26 at 2:56 PM
$BDSX insider buying. Preliminary earnings release fuels price surge.
0 · Reply
WiseSolution
WiseSolution Jan. 26 at 2:39 PM
$BDSX impressive the largest insiders averages up with new purchase of 82k shares
0 · Reply
Red2Profit
Red2Profit Jan. 24 at 2:59 PM
$BDSX Break 13.10 and we'll hit 17.02. With a catalyst and volume we can see 26-32 by spring.
0 · Reply
v92
v92 Jan. 23 at 4:48 PM
$BDSX Nice little squeeze just getting started.
0 · Reply